NCT05912192View on ClinicalTrials.gov

The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis

NACompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

April 14, 2023

Study Completion Date

April 14, 2023

Conditions
Allergic Rhinitis
Interventions
DRUG

Elonide Nasal Spray

50mcg/dose One puff for each nostrils twice daily

DRUG

Nasonex Nasal Spray

50mcg/dose One puff for each nostrils twice daily

DRUG

Normal saline

50mcg/dose of 0.9% sodium chloride One puff for each nostrils twice daily

Trial Locations (1)

56000

Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras

Sponsors
All Listed Sponsors
collaborator

HOE pharmaceuticals Sdn. Bhd.

UNKNOWN

lead

National University of Malaysia

OTHER

NCT05912192 - The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis | Biotech Hunter | Biotech Hunter